Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion type Assertion NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_head.
- NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_provenance.
- NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion evidence source_evidence_literature NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_provenance.
- NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion SIO_000772 11919393 NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_provenance.
- NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion wasDerivedFrom befree-20140225 NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_provenance.
- NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_assertion wasGeneratedBy ECO_0000203 NP169977.RA6UHLzVVrK_YKdNj63rztQQWSqMgcy9KbeXyODAXgfRY130_provenance.